Marc Semigran's Net Worth

$1.97 Million

Estimate Recalculated Nov 1, 2024 02:23PM EST

Who is Marc Semigran

Marc Semigran has an estimated net worth of $1.97 Million. This is based on reported shares across multiple companies, which include Social Capital Suvretta Holdings Corp. III, MyoKardia Inc, Renovacor, Inc., and Edgewise Therapeutics, Inc..

SEC CIK

Marc Semigran's CIK is 0001691494

Past Insider Trading and Trends

2018 was Marc Semigran's most active year for acquiring shares with 6 total transactions. Marc Semigran's most active month to acquire stocks was the month of December. 2022 was Marc Semigran's most active year for disposing of shares, totalling 5 transactions. Marc Semigran's most active month to dispose stocks was the month of November. 2018 saw Marc Semigran paying a total of $730,482.32 for 88,652 shares, this is the most they've acquired in one year. In 2018 Marc Semigran cashed out on 90,000 shares for a total of $2,679,006.06, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Social Capital Suvretta Holdings Corp. III

Investor
Updated Jun 29, 2021
Form 3
Jun 29, 2021
Showing 1 results

MyoKardia Inc

Chief Medical Officer
Updated Feb 12, 2019
Form 4
33.40K
Feb 12, 2019
33.40K
Grant
Feb 08
Form 4
-31.78%
-517.00
$44.26
-$22.88K
Jan 09, 2019
1.11K
Tax
Jan 07
Form 4
Jan 03, 2019
5.60K
Options
Jan 01
Form 4
302.00
$42.16
$12.73K
Dec 20, 2018
302.00
Grant
Oct 31
Form 4
-25.71%
-45.00K
$37.74
-$1.96M
Sep 06, 2018
130.00K
Sale
ScheduledSep 04 - Sep 05
Form 4
6.25K
Jun 29, 2018
6.25K
Grant
Jun 28
Form 4
37.10K
Jan 18, 2018
37.10K
Grant
Jan 16
Form 4
175.00K
Dec 05, 2016
175.00K
Grant
Dec 01
Form 3
Dec 05, 2016
Showing 9 results

Renovacor, Inc.

Chief Medical Officer
Updated Dec 05, 2022
Form 4
-100.00%
-311.12K
Dec 05, 2022
Disposition
Dec 01
Form 4
148.40%
52.27K
Jan 26, 2022
87.50K
Grant
Jan 24
Form 4
88.99K
Dec 22, 2021
88.99K
Grant
Dec 20
Form 4
169.85K
Sep 08, 2021
169.85K
Grant
Sep 03
Form 3
Sep 07, 2021
35.23K
Showing 5 results

Edgewise Therapeutics, Inc.

Chief Development Officer
Updated Aug 14, 2024
Form 4
161.88K
Aug 14, 2024
161.88K
Grant
Aug 12
Form 4
133.33K
Aug 18, 2023
133.33K
Grant
Aug 17
Form 4
300.00K
Jan 03, 2023
300.00K
Grant
Dec 30
Form 3
Dec 22, 2022
Showing 4 results